Recruiting Sarcoidosis Studies in Philadelphia
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
This is a Phase 2, randomized, double-blind, placebo-controlled, adaptive, multicenter study to evaluate the efficacy, safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of OATD-01...
A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis....
About Sarcoidosis Clinical Trials in Philadelphia
Sarcoidosis is an inflammatory disease characterized by the formation of granulomas (clumps of inflammatory cells) in various organs, most commonly the lungs and lymph nodes. Many cases resolve on their own, but some require treatment with corticosteroids or immunosuppressive medications.
There are currently 2 sarcoidosis clinical trials recruiting participants in Philadelphia, PENNSYLVANIA. These studies are seeking a combined 124 participants. Research is being sponsored by Molecure S.A., Priovant Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Sarcoidosis Clinical Trials in Philadelphia — FAQ
Are there sarcoidosis clinical trials in Philadelphia?
Yes, there are 2 sarcoidosis clinical trials currently recruiting in Philadelphia, PENNSYLVANIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What sarcoidosis treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoidosis.
Data updated March 2, 2026 from ClinicalTrials.gov